Cargando…

High‐Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network

BACKGROUND: We sought to study the prevalence of high‐sensitivity troponin and its association with cardiac structure and outcomes in ambulatory and hospitalized patients with heart failure with a preserved ejection fraction (HFpEF). METHODS AND RESULTS: A post hoc analysis utilized data from HFpEF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fudim, Marat, Ambrosy, Andrew P., Sun, Jie‐Lena, Anstrom, Kevin J., Bart, Bradley A., Butler, Javed, AbouEzzeddine, Omar, Greene, Stephen J., Mentz, Robert J., Redfield, Margaret M., Reddy, Yogesh N.V., Vaduganathan, Muthiah, Braunwald, Eugene, Hernandez, Adrian F., Borlaug, Barry A., Felker, G. Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405612/ https://www.ncbi.nlm.nih.gov/pubmed/30561266 http://dx.doi.org/10.1161/JAHA.118.010364

Ejemplares similares

Implications of peripheral oedema in heart failure with preserved ejection fraction: a heart failure network analysis
por: Fudim, Marat, et al.
Publicado: (2020)

Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction
por: AbouEzzeddine, Omar F., et al.
Publicado: (2017)

Growth differentiation factor‐15, treatment with liraglutide, and clinical outcomes among patients with heart failure
por: Sharma, Abhinav, et al.
Publicado: (2021)

High-sensitivity C-reactive protein in heart failure with preserved ejection fraction
por: DuBrock, Hilary M., et al.
Publicado: (2018)

Hyperkalemia in Heart Failure: Probably Not O“K”
por: Fudim, Marat, et al.
Publicado: (2018)

Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018
por: Salah, Husam M., et al.
Publicado: (2022)

Intravenous iron infusion in patients with heart failure: a systematic review and study‐level meta‐analysis
por: Salah, Husam M., et al.
Publicado: (2023)

Innovation in Ambulatory Care of Heart Failure in the Era of Coronavirus Disease 2019
por: Leiva, Orly, et al.
Publicado: (2020)

Role of Volume Redistribution in the Congestion of Heart Failure
por: Fudim, Marat, et al.
Publicado: (2017)

Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016)

Expected vs Actual Outcomes of Elective Initiation of Inotropic Therapy During Heart Failure Hospitalization
por: Snipelisky, David, et al.
Publicado: (2020)

Shielding the Heart: Preload Reduction Therapies in Heart Failure
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2023)

A Machine Learning Methodology for Identification and Triage of Heart Failure Exacerbations
por: Morrill, James, et al.
Publicado: (2021)

A rationale for dedicated trials of combination therapy in heart failure
por: Blumer, Vanessa, et al.
Publicado: (2022)

The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
por: Greene, Stephen J., et al.
Publicado: (2013)

Frailty and heart failure: State‐of‐the‐art review
por: Talha, Khawaja M., et al.
Publicado: (2023)

Regional Adiposity and Risk of Heart Failure and Mortality: The Jackson Heart Study
por: Rao, Vishal N., et al.
Publicado: (2021)

Ultrafiltration in Acute Heart Failure: Implications of Ejection Fraction and Early Response to Treatment From CARRESS‐HF
por: Fudim, Marat, et al.
Publicado: (2020)

Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines
por: Branca, Luca, et al.
Publicado: (2020)

Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial
por: Sharma, Abhinav, et al.
Publicado: (2018)

Splanchnic Nerve Ablation for Volume Management in Heart Failure
por: Fudim, Marat, et al.
Publicado: (2022)

Effects of COVID-19 on heart failure admissions
por: Chouairi, Fouad, et al.
Publicado: (2023)

Unmasking Hydroxychloroquine Cardiotoxicity in a Patient With Heart Failure and Chronotropic Incompetence
por: Ezzeddine, Fatima M., et al.
Publicado: (2021)

Identification of Patients with Preclinical Heart Failure with preserved Ejection Fraction Using the H(2)FPEF Score
por: Koepp, Katlyn E., et al.
Publicado: (2022)

Tackling Inflammation in Heart Failure With Preserved Ejection Fraction: Resurrection of Vagus Nerve Stimulation?
por: Kittipibul, Veraprapas, et al.
Publicado: (2022)

Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction After a Recent Worsening Heart Failure Event
por: Carnicelli, Anthony P., et al.
Publicado: (2021)

What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials
por: Fiuzat, Mona, et al.
Publicado: (2022)

Interaction of Body Mass Index on the Association Between N‐Terminal‐Pro‐b‐Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND‐HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)
por: Bhatt, Ankeet S., et al.
Publicado: (2018)

Heart Failure Remote Monitoring: A Review and Implementation How-To
por: Kobe, Elizabeth A., et al.
Publicado: (2023)

The Role of Ambulatory Heart Failure Clinics to Avoid Heart Failure Admissions
por: He, Jessica, et al.
Publicado: (2019)

Audicor Remote Patient Monitoring: FDA Breakthrough Device and Technology for Heart Failure Management
por: Fudim, Marat, et al.
Publicado: (2022)

Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction
por: Ostrominski, John W., et al.
Publicado: (2022)

Novel findings of respiratory rate increases using the multisensor HeartLogic heart failure monitoring algorithm in COVID-19-positive patients: a case series
por: Yapejian, Andrea Rebecca, et al.
Publicado: (2021)

Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta‐analysis
por: Butler, Javed, et al.
Publicado: (2020)

Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?
por: Tkaczyszyn, Michał, et al.
Publicado: (2023)

Synchronized Diaphragmatic Stimulation for the Treatment of Symptomatic Heart Failure: A Novel Implantable Therapy Concept
por: Fudim, Marat, et al.
Publicado: (2022)

Impact of exercise on pulmonary artery pressure in patients with heart failure using an ambulatory pulmonary artery pressure monitor
por: Khedraki, Rola, et al.
Publicado: (2023)

Reductions in Heart Failure Hospitalizations During the COVID-19 Pandemic
por: HALL, MICHAEL E., et al.
Publicado: (2020)

Impact of COVID-19 on Heart Failure Clinical Trials: Insights From the Heart Failure Collaboratory
por: Bhatt, Ankeet S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uf4428048709k6smh5q7hcve5q